Financial Snapshot

Revenue
$0.00
TTM
Gross Margin
Net Earnings
-$14.17M
TTM
Current Assets
Q2 2024
Current Liabilities
Q2 2024
Current Ratio
387.25%
Q2 2024
Total Assets
Q2 2024
Total Liabilities
Q2 2024
Book Value
$14.22M
Q2 2024
Cash
Q2 2024
P/E
-1.332
Nov 29, 2024 EST
Free Cash Flow
-$18.04M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019
Revenue $107.0K $861.0K $18.53M $7.719M $10.15M
YoY Change -87.57% -95.35% 140.08% -23.95%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019
Revenue $107.0K $861.0K $18.53M $7.719M $10.15M
Cost Of Revenue $0.00 $310.0K
Gross Profit $7.720M $9.840M
Gross Profit Margin 100.01% 96.95%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019
Selling, General & Admin $26.91M $38.09M $21.24M $14.01M $7.440M
YoY Change -29.35% 79.34% 51.59% 88.31%
% of Gross Profit 181.48% 75.61%
Research & Development $7.199M $57.89M $57.28M $33.14M $23.54M
YoY Change -87.56% 1.07% 72.82% 40.8%
% of Gross Profit 429.33% 239.23%
Depreciation & Amortization $1.520M $5.507M $2.301M $790.0K $480.0K
YoY Change -72.4% 139.33% 191.27% 64.58%
% of Gross Profit 10.23% 4.88%
Operating Expenses $34.11M $116.5M $78.52M $47.16M $30.99M
YoY Change -70.71% 48.32% 66.51% 52.16%
Operating Profit -$83.86M -$115.6M -$59.99M -$39.44M -$21.15M
YoY Change -27.45% 92.7% 52.11% 86.46%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019
Interest Expense $1.570M $252.0K $22.00K $110.0K $490.0K
YoY Change 523.02% 1045.45% -80.0% -77.55%
% of Operating Profit
Other Income/Expense, Net $4.053M $947.0K $1.825M $95.00K $40.00K
YoY Change 327.98% -48.11% 1821.05% 137.5%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019
Pretax Income -$78.22M -$114.6M -$58.16M -$39.34M -$20.75M
YoY Change -31.78% 97.12% 47.84% 89.6%
Income Tax -$3.461M $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$74.75M -$114.6M -$58.16M -$39.34M -$20.75M
YoY Change -34.8% 97.12% 47.84% 89.6%
Net Earnings / Revenue -69863.55% -13315.45% -313.84% -509.66% -204.43%
Basic Earnings Per Share -$46.59 -$2.40 -$1.48
Diluted Earnings Per Share -$46.59 -$2.40 -$1.484M -$834.4K -$440.1K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019
Cash & Short-Term Investments $25.12M $71.04M $133.5M $99.70M $42.20M
YoY Change -64.63% -46.78% 33.88% 136.26%
Cash & Equivalents $25.12M $71.04M $133.5M $99.70M $42.20M
Short-Term Investments
Other Short-Term Assets $723.0K $3.369M $8.576M $5.400M $1.700M
YoY Change -78.54% -60.72% 58.81% 217.65%
Inventory
Prepaid Expenses
Receivables $0.00 $144.0K $494.0K $1.000M $1.200M
Other Receivables $0.00 $0.00 $0.00 $100.0K $3.500M
Total Short-Term Assets $25.85M $74.55M $142.6M $106.2M $48.60M
YoY Change -65.33% -47.7% 34.23% 118.52%
Property, Plant & Equipment $27.18M $48.69M $24.69M $7.000M $3.800M
YoY Change -44.18% 97.21% 252.69% 84.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.348M $6.800M $7.173M $1.200M $200.0K
YoY Change -65.47% -5.2% 497.75% 500.0%
Total Long-Term Assets $29.53M $88.39M $82.82M $59.10M $55.00M
YoY Change -66.6% 6.73% 40.13% 7.45%
Total Assets $55.37M $162.9M $225.4M $165.3M $103.6M
YoY Change
Accounts Payable $141.0K $1.097M $3.737M $2.600M $700.0K
YoY Change -87.15% -70.64% 43.73% 271.43%
Accrued Expenses $3.265M $13.59M $11.05M $5.200M $4.000M
YoY Change -75.98% 22.97% 112.56% 30.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.084M $14.69M $14.79M $11.50M $7.300M
YoY Change -72.2% -0.68% 28.61% 57.53%
Long-Term Debt $0.00 $14.65M $7.000K $1.800M $0.00
YoY Change -100.0% 209228.57% -99.61%
Other Long-Term Liabilities $28.40M $34.43M $4.887M $11.20M $9.200M
YoY Change -17.49% 604.42% -56.37% 21.74%
Total Long-Term Liabilities $28.40M $49.08M $4.894M $13.00M $9.200M
YoY Change -42.13% 902.82% -62.35% 41.3%
Total Liabilities $32.49M $67.23M $23.15M $28.00M $20.00M
YoY Change -51.68% 190.46% -17.34% 40.0%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019
Basic Shares Outstanding 1.605M 47.69M 39.20M
Diluted Shares Outstanding 1.605M 47.69M 39.20M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $18.868 Million

About Finch Therapeutics Group, Inc.

Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. The company is headquartered in Boston, Massachusetts. The company went IPO on 2021-03-19. The company is focused on realizing the value of its intellectual property estate and other assets, while supporting the advancement of its microbiome technology through partnerships and collaborations. The company has an intellectual property estate, including more than 113 issued U.S. and foreign patents with relevance for both donor-derived and donor-independent microbiome therapeutics in a range of potential indications. Its assets include CP101, an orally administered microbiome candidate designed for the prevention of recurrent C. difficile infection (CDI), with positive clinical data from a Phase II randomized, placebo-controlled trial and a Phase II open-label trial, and pre-clinical assets that are designed to target ulcerative colitis, Crohn’s disease, and autism spectrum disorder. Additionally, it has also developed a biorepository of strains and samples.

Industry: Biological Products, (No Diagnostic Substances) Peers: ASSEMBLY BIOSCIENCES, INC. aTYR PHARMA INC GELESIS HOLDINGS, INC. Surrozen, Inc./DE Fortress Biotech, Inc. Cue Biopharma, Inc. PDS Biotechnology Corp PALVELLA THERAPEUTICS, INC. Xilio Therapeutics, Inc.